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Background: The ethnomedical uses of Haematostaphis barteri commonly known as blood plum has been 
documented in literature. The efficacy of its stem bark extract in management of liver diseases is well acclaimed 
among communities of Northern Nigeria. 
Objective: To evaluate the hepatoprotective activity of methanol stem bark extract of Haematostaphis barteri against 
paracetamol and carbon tetrachloride (CCl4)-induced hepatotoxicity in Wistar rats.  
Methodology: Phytochemical and acute toxicity studies were carried out. Liver damage was induced in different 
groups of Wistar rats using paracetamol (3 g/kg) and 1 ml/kg of CCl4 (1:1 in olive oil). The effect of Haematostaphis 
barteri extract was tested for hepatoprotective activity by evaluating serum biochemical parameters and liver 
histology. The extract was also tested for antioxidant activity using in-vitro DPPH free radical scavenging method.  
Results: Phytochemicals present include tannins, sterols, alkaloids, saponins, triterpenes, flavonoids and 
anthraquinones. Oral median lethal dose was estimated to be >5000 mg/kg. Pre-treatment with the extract (250, 500 
and 1000 mg/kg) significantly (p<0.05) reduced alanine aminotransferase and alkaline phosphatase levels compared 
to paracetamol and CCl4 toxic groups respectively. These results were supported by the protection against 
hepatocellular necrosis in the extract treated groups as well as the DPPH radical scavenging activity. 
Conclusion: The results obtained suggest the stem bark extract of Haematostaphis barteri possesses hepatoprotective 
activity. 
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1. Introduction 
The liver is the second largest organ in human body and 
has metabolic, secretory, synthetic, excretory and 
storage functions (Kandimalla et al, 2016). It is involved 
in the metabolism of drugs, toxins and food substances 
which makes it vulnerable to a wide variety of 
metabolic, toxic, microbial, circulatory and neoplastic 
insults (Crowford, 2004; Nirmala et al, 2012). Liver 
disease is a major cause of morbidity and mortality 
among human population and has a worldwide 
distribution (Mnddrey, 2001). The dominant primary 
diseases of the liver are viral hepatitis, alcoholic liver 
disease, and hepatocellular carcinoma (Crowford, 2004; 
Nirmala et al, 2012). Treatment of liver diseases are 
associated with many problems; the conventional drugs 
used are not only inadequate but associated with 
serious adverse effects (Porceddu et al, 2012). In view 
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of the limited treatment options and significant adverse 
effects associated with the conventional drugs, novel 
prophylactic and therapeutic agents against liver 
diseases are urgently needed (Hong et al, 2015). 
Medicinal plants have been widely used by urban and 
rural populations in treating various diseases including 
liver problems (Jordan et al, 2010, Wang et al, 2012). 
The World Health Organization has recognized the fact 
that about 80% of the population in developing 
countries rely on traditional medicine for their 
healthcare needs (WHO, 2013). This can be explained 
due to the fact that traditional medicine is more 
affordable, accessible and culturally acceptable in many 
parts of the world.  
Haematostaphis barteri is a member of Anacardiaceae 
family, a perennial tree that grows up to 8 meters high 
by 65 cm girth. It is found in dry Savannah from Upper 
Volta to Nigeria and also in Cameroun and Sudan. It is 
commonly known as blood plum in English and the 
vernacular names include Tsamiyar lamarudu (in 
Hausa) and Tursuhi or Tursahi (in Fulfulde). It is used 
by communities of Northern Nigeria in the treatment of 
liver diseases (Burkill, 1985).  Decoction of the stem 
bark is orally taken mostly by people of Northern 
Nigeria to cure diseases such as hepatitis and sleeping 
sickness (Abubakar et al, 2014; Boampong et al, 2015). 
Previous studies on H. barteri showed that the seeds 
contain unsaturated higher fatty acids (Eicosadienoic 
and Erucic acid) (Eromosele and Eromosele, 2002) as 
well as saturated fatty acids. The fruit extract of H. 
barteri was reported to cause an increase in 
haemoglobin concentration, packed cell volume and 
erythrocytes count in albino rats (Abubakar et al, 2014), 
while the aqueous stem bark extract possesses curative 
and prophylactic antimalarial activities as well as 
antioxidant properties (Boampong et al, 2015). To our 
knowledge, the hepatoprotective potentials of the stem 
bark extract has not been scientifically validated and 
therefore, this study was aimed at evaluating the 
hepatoprotective properties of the methanol stem bark 
extract of H. barteri against paracetamol and carbon 
tetrachloride (CCL4)-induced liver damage in Wistar 
rats. 
2. Materials and Methods 
2.1 Drugs and Chemicals 
Analar grade paracetamol powder (Sigma Chemicals Co, 
USA), Carbon tetrachloride (BDH Ltd Poole, England), 
Silymarin (Micro Labs Limited, India), Olive oil 
(Metaluni S.P.A., Italy), Normal saline (0.9%w/v NaCl 
Isotonic Solution) (Dana Pharmaceuticals Limited, 
Nigeria), 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) 
powder (Sigma Chemicals Co, USA), Substrate and 
buffer solutions  (Randox, UK) 
2.2 Experimental animals 
Wistar albino rats 180-220 g of either sex were 
obtained from the animal facility of Department of 
Pharmacology and Therapeutics, Bayero University, 
Kano. The rats were kept in plastic rat cages with metal 
coverlids and soft wood shavings as bedding material. 
They were placed on commercial rat feed (Vital feed®, 
Kano) and water ad libitum and maintained in well 
ventilated room under natural light and dark cycle. All 
experiments performed on the laboratory animals were 
approved by the University Animal Ethics Committee. 
2.3 Plant Material  
Haematostaphis barteri stem bark was collected in July, 
2014 from Hanwa area of Sabon Gari Local Government, 
Kaduna State. The plant was identified and 
authenticated by a taxonomist, Mr. Musa Muhammad of 
the Department of Biological Sciences, Ahmadu Bello 
University Zaria. A specimen number 2796 was 
assigned and a voucher specimen was deposited in the 
Herbarium section of the department for future 
reference.  
2.4 Preparation of plant extract 
The stem bark of Haematostaphis barteri was air dried 
under shade and then mechanically powdered using 
pestle and mortar. The methanol stem bark extract was 
prepared by subjecting 1280 g of the powdered bark to 
maceration using 10 liters of 70% v/v methanol (in 30% 
water) followed by intermittent stirring for 72 hrs. The 
macerate was filtered using Whatman filter paper (No. 
1) and the filtrate obtained was concentrated over a 
water bath maintained at 50 ºC until extraction solvent 
was completely dry. The extract was then stored in a 
desiccator until required in the main study.   
2.5 Phytochemical screening 
Basic phytochemical screening tests were carried out on 
the stem bark extract of Haematostaphis barteri using 
standard procedures to identify its phytochemical 
constituents (Evans, 2002).  
2.6 Acute toxicity study 
Oral acute toxicity testing of the extract was carried out 
in rats according to Lorke’s method (1983). The study 
was in two phases; in the first phase, three groups of 
three rats each received 10, 100 and 1000 mg/kg of the 
extract. The rats were observed for signs of toxicity and 
death for 24 hrs. In the second phase, three rats were 
used and each was administered 1600, 2900 and 5000 
mg/kg of the extract. The rats were also observed for 
signs of toxicity and death for 24 hrs. Thereafter, the 
oral median lethal dose (LD50) was estimated as the 
geometric mean of the lowest lethal dose and the 
highest non-lethal dose. 
2.7 Assessment of hepatoprotective activity  
Paracetamol-induced hepatotoxicity 
The method described by Ajith et al, (2007) was 
adapted with some modifications. In this study, thirty 
rats were divided into 6 groups of 5 rats each. Group I 
rats (Normal control) received normal saline, 1 ml/kg, 
p.o. for 5 days. Group II rats (Toxic control) received 
paracetamol (3 g/kg, p.o.) on the 4th day. Group III 
(Standard) was treated with standard drug silymarin 
(100 mg/kg p.o.) for 5 days and on the 4th day, 
paracetamol (3 g/kg, p.o.) was given 1 hour after the 
treatment with silymarin. Groups IV, V and VI were 
treated with the extract (at doses of 250, 500 and 1000 
mg/kg respectively) p.o. daily for 5 days and on the 4th 
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day paracetamol (3 g/kg, p.o.) was given 1 hour after 
treatment with the extracts. All the animals were 
sacrificed 48 hours after the dose of paracetamol under 
mild chloroform anaesthesia. The blood samples were 
collected in plain sample bottles and then centrifuged at 
a speed of 4000 revolutions per minute to separate the 
serum. The serum samples were stored at −80°C. 
Biochemical parameters such as aspartate 
aminotransferase (AST), alanine aminotransferase 
(ALT), alkaline phosphatase (ALP), as well as serum 
determination of total bilirubin (TB) and conjugated 
bilirubin (CB) were then analyzed using 
spectrophotometer. 
Carbon tetrachloride (CCl4)-induced hepatotoxicity 
The method described by Jain et al, (2006) was adapted 
with some modifications. Thirty rats were divided into 
six groups containing 5 rats each. Group I rats (Normal 
control) received Normal saline, 1 ml/kg, p.o. for 5 days. 
Group II rats (Toxic group) received 1 ml/kg of CCl4 (1:1 
in olive oil, i.p.), on the 3rd and 4th days. Group III rats 
(Standard) received silymarin (100 mg/kg p.o.) for 5 
days and on the 3rd and 4th day, CCl4 (1 ml/kg i.p.) was 
administered 1 hour after the treatment with silymarin. 
Group IV, V and VI rats received 250, 500 and 1000 
mg/kg of the extract p.o. per day respectively for 5 days 
and on the 3rd  and 4th  days CCl4 (1 ml/kg i.p.) was 
administered 1 hour after the treatment with the 
extract. The rats were also sacrificed 48 hours after the 
last injection of CCl4 under mild chloroform anaesthesia. 
The blood samples were collected in plain sample 
bottles and then centrifuged at a speed of 4000 
revolutions per minute to separate the serum. The 
samples were stored at −80°C and the biochemical 
parameters (AST, ALT, ALP, TB and CB) were also 
analysed.  
2.8 Histopathological examination 
Sections of tissue from liver were used for 
histopathological examination after dissecting the 
animals. Tissues were fixed in 10% buffered formalin 
(pH 7.2) and dehydrated through a series of ethanol 
solutions, embedded in paraffin and routinely 
processed for histological analysis. Sections of 5 μm 
thickness were cut and stained with haematoxylin-eosin 
for examination. The stained tissues were observed 
through a Leitz microscope at x250 magnification and 
photographed by a Scope tek DCM500 camera. 
2.9 Antioxidant assay  
The DPPH radical scavenging activity of the plant 
extracts was determined according to the method 
described by Chan et al, (2007). DPPH solution was 
prepared by dissolving 6 mg of DPPH in 100 ml of 
methanol. To 1 ml of various concentrations of the 
methanol stem bark of the extract (20, 40, 60, 80, 100 
μg/ml), 2 ml of DPPH solution (0.1 mM) was added. An 
equal amount of methanol and DPPH served as control. 
The mixture was shaken vigorously after being kept for 
30 minutes. The absorbance of the resulting solution 
was taken using ultraviolet (UV) spectrophotometer at 
520 nm. The experiments were performed in triplicate 
and the percentage scavenging activity of the extract on 
DPPH radical was calculated. 
2.10 Statistical analysis 
Analysis of data was done using Minitab version 17. 
Differences between the mean biochemical parameters 
were analyzed using one way analysis of variance 
(ANOVA) followed by Dunnett’s post-hoc test. The 
results were considered significant at p-value of <0.05. 
Data were presented as Mean ± Standard Error of the 
Mean (S.E.M.) in tables.  
3. Results  
Phytochemical analysis 
Percentage yield of methanol stem bark extract of 
Haematostaphis barteri was 4.22% w/w. Preliminary 
phytochemical screening of the extract showed the 
presence of alkaloids, flavonoids, tannins, cardiac 
glycosides, triterpenes, saponins, anthraquinones and 
carbohydrates. 
Acute toxicity study 
No signs and symptoms of toxicity were observed in 
both phases of the acute toxicity study. Therefore, the 
oral LD50 of the methanol stem bark extract of 
Haematostaphis barteri was estimated to be >5000 
mg/kg body weight in rats.  
Effect of methanol stem bark extract of 
Haematostaphis barteri on serum biochemical 
markers in paracetamol-induced hepatotoxic rats 
Administration of paracetamol caused significant 
(p<0.05) increase in ALT and AST levels compared to 
normal saline control group. Pre-treatment with 
silymarin caused significant (p<0.05) decrease in ALT 
levels as compared with the paracetamol toxic group. 
Pre-treatment of the rats with H. barteri extract at all 
the doses tested also caused significant (p<0.05) 
decrease in ALT levels when compared with the toxic 
group. However, pre-treatment with the extract at all 
the doses tested did not show a significant decrease in 
serum AST, ALP and serum bilirubin levels as compared 
to paracetamol toxic group (Table 1). 
Effect of methanol stem bark extract of 
Haematostaphis barteri on histopathological 
parameters in paracetamol-induced hepatotoxic 
rats 
Liver sections of saline control group showed normal 
lobular architecture and normal hepatic cells (Plate Ia) 
while liver section from paracetamol toxic group 
showed hepatocellular necrosis with kupffer cell 
hyperplasia (Plate Ib). Liver section from silymarin 
treated group showed mild hepatocellular necrosis 
(Plate Ic). Histopathological study of the rats’ liver 
treated with H. barteri at a dose of 250 mg/kg showed 
hydropic changes, slight necrosis of the hepatocytes and 
kupffer cell hyperplasia (Plate Id). Treatment with 500 
mg/kg of H. barteri showed intense pyknosis with 
moderate hepatocellular necrosis of the liver (Plate Ie). 
Treatment with 1000 mg/kg of H. barteri showed mild 
vacoulation in the liver with lymphocyte hyperplasia 
(Plate If). 
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Table 1: Effect of methanol stem bark extract of Haematostaphis barteri against paracetamol-induced hepatotoxicity 













NS 12.00±1.41 9.80±0.66 124.20±11.20 3.20±1.96 6.40±3.92 
PCM 38.60±4.72** 48.20±8.28** 148.60±20.10 3.20±1.96 9.60±3.92 
SLY+PCM        19.80±1.85* 22.20±5.87 203.80±55.20 1.60±1.60 6.40±3.92 
HB(250)+PCM     17.40±0.93* 10.80±1.56 236.60±24.90 3.20±1.96 6.40±3.92 
HB(500)+PCM     27.80±1.85* 55.40±14.90 273.40±37.90 4.80±1.96 13.00±6.15 
HB(1000)+PCM   23.00±2.35* 50.20±16.00 271.20±87.50 3.20±1.96 9.80±6.50 
Data presented as Mean ± S.E.M. *= p< 0.05 compared to PCM toxic group, **= p< 0.05 compared with normal saline (NS) control 
group - One way ANOVA followed by Dunnett’s test; n=5, ALT = Alanine transaminase, ALP = Alkaline phosphatase, AST = Aspartate 
transaminase, HB=Haematostaphis barteri, CB=Conjugated bilirubin, TB=Total bilirubin, PCM=Paracetamol, SLY = Silymarin 
 
  
Plate Ia: Section of rat liver of administered normal 
saline showing normal hepatocytes 
 
Plate Ib: Section of rat liver of paracetamol toxic group 
showing hepatocellular necrosis (A) with kupffer cell 
hyperplasia (B) 
  
Plate Ic: Section of rat liver administered silymarin 
showing mild hepatocellular necrosis (A) 
Plate Id: Section of rat liver administered H. barteri (250 
mg/kg) showing slight necrosis of the hepatocytes (A) 
with kupffer cell hyperplasia (B) 
  
Plate Ie: Section of rat liver administered H. barteri (500 
mg/kg) showing intense pyknosis with moderate 
hepatocellular necrosis (A) 
Plate If: Section of rat liver administered H. barteri (1000 
mg/kg) showing mild vacoulation (A) with lymphocyte 
hyperplasia (B) 
Plate I: Effects of methanol stem bark extract of H. barteri on histopathological changes in liver of rats in paracetamol-
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Effect of methanol stem bark extract of 
Haematostaphis barteri on serum biochemical 
markers in CCL4-induced hepatotoxic rats 
Administration of CCl4 caused significant (p<0.05) 
increase in ALT, AST and ALP levels when compared to 
normal saline control group. Treatment with silymarin 
caused significant (p<0.05) reduction in serum ALT, 
AST and ALP when compared with CCl4 toxic group. The 
extract at all the dose tested significantly (p<0.05) 
reduced the mean serum ALP levels compared with CCl4 
toxic group. The reduction in serum AST was only 
significant (p<0.05) at 500 mg/kg of the extract when 
compared to CCl4 toxic group (Table 2). There was no 
significant (p>0.05) reduction in serum bilirubin levels 
in the silymarin and H. barteri treated groups when 
compared with CCl4 toxic group (Table 2). 
Effect of methanol stem bark extract of 
Haematostaphis barteri on histopathological 
parameters in CCL4-induced hepatotoxic rats 
Liver section from saline control group showed normal 
lobular architecture and normal hepatic cells (Plate 
IIa). CCl4 toxic group liver showed hepatocellular 
necrosis (Plate IIb). Liver from silymarin treated group 
showed moderate necrosis (Plate IIc). Liver section 
from H. barteri treated group at a dose of 250 mg/kg 
showed moderate hepatocellular necrosis with kupffer 
cell hyperplasia (Plate IId). Treatment of the rats with 
500 mg/kg of H. barteri extract caused moderate 
hepatocellular necrosis of the liver (Plate IIe) while 
treatment with 1000 mg/kg of H. barteri showed 
intense hepatocellular necrosis of the liver tissue (Plate 
IIf). 
3.4  DPPH radical scavenging activity 
The DPPH scavenging activity of methanol stem bark 
extract of Haematostaphis barteri at different 
concentrations are presented in Table 3. The inhibition 
was not dose-dependent. 
 
Table 2: Effect of methanol stem bark extract of Haematostaphis barteri on carbon tetrachloride-induced 













NS 10.40±1.170 10.80±1.02 126.20±11.50 3.20±1.96 6.40±3.92 
CCl4 29.20±1.39** 77.20±9.61** 545.00±151.00** 6.40±3.92 6.40±7.38 
SLY+ CCl4 15.40±2.09* 13.80±0.58* 165.20±20.10* 3.20±1.96 6.40±3.92 
HB(250)+ CCl4 25.40±3.66 66.60±9.45 204.80±18.40* 1.60±1.60 6.40±3.92 
HB(500)+ CCl4 22.20±3.57 30.80±9.98* 245.40±29.00* 1.60±1.60 6.40±3.92 
HB(1000)+ CCl4 28.80±1.39 62.40±15.10 154.20±5.30* 3.20±3.20 9.60±6.40 
Data were presented as Mean ± S.E.M. *=p<0.05 compared with PCM toxic group, **=p<0.05 compared with normal saline (NS) 
control group - One way ANOVA followed by Dunnett’s test, n= 5, HB = Haematostaphis barteri, ALT = Alanine transaminase, 
ALP=Alkaline phosphatase, AST=Aspartate transaminase, CB=Conjugated bilirubin, TB=Total bilirubin, CCl4 = Carbon tetrachloride, 
SLY = Silymarin 
Table 3: Quantitative DPPH assay of the stem bark extract of Haematostaphis barteri 
S/N   Concentration (μg/ml) AB AE % Inhibition 
1 20 0.469 0.220 53.09 
2 40 0.809 0.349 56.86 
3 60 0.827 0.439 46.92 
4 80 0.914 0.531 41.90 
5 100 0.796 0.680 14.57 
   AB= absorbance of control, AE= absorbance of the Extract, Wavelength = 520 nm 
 
4.0 Discussion 
The biological actions produced by plant extracts are 
usually attributed to the presence of secondary 
metabolites in them (Kensa and Yasmin, 2011). The 
phytochemical constituents found present in the 
methanol stem bark extract of H. barteri in this study 
were largely corroborative of the findings of Tadzabia et 
al, (2013). Some of these constituents like flavonoids, 
triterpenes and tannins have been reported to exert 
hepatoprotective activity (Shimoda et al., 2008; 
Kandimalla et al., 2016) and are thus suggested to 
contribute to the observed hepatoprotection of H. 
barteri stem bark extract. The oral median lethal dose of 
the methanol stembark extract of H. barteri in rats was 
estimated to be >5000 mg/kg. According to Lu, (1996) 
classification of LD50 values, it implies that the extract is 
practically non-toxic in rats when administered orally 
as no death was recorded in both phases of the study.  
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Plate IIa: Section of rat liver showing normal hepatocytes 
in normal saline control group 
 
Plate IIb: Section of rat liver administered CCl4 showing 
hepatocellular necrosis (A) 
  
Plate IIc: Section of rat liver administered silymarin 
showing moderate hepatocellular necrosis (A) 
Plate IId: Section of rat liver administered H. barteri (250 
mg/kg) showing moderate hepatocellular necrosis (A) 
with kupffer cell hyperplasia (B) 
 
  
Plate IIe: Section of rat liver of administered H. barteri 
(500 mg/kg) showing moderate hepatocellular necrosis 
(A) 
 
Plate IIf: Section of rat liver administered H. barteri 
(1000 mg/kg) showing intense hepatocellular necrosis 
(A) 
Plate II: Effect of H. barteri on histopathological changes in liver of rats in CCl4-induced hepatotoxicity. Magnification 
(H and E ×250) 
 
Hepatocellular damage can lead to loss of functional 
integrity of parenchymal cells and leakage of liver 
enzymes resulting in their elevation in the serum 
(Daniel, 2015). In this study, administration of 
paracetamol (3 g/kg) resulted in hepatic damage and 
showed a significant serum elevation of enzyme and 
non-enzyme markers of liver damage (ALT, AST, ALP, 
conjugated and total bilirubin) as well as hepatocellular 
necrosis. Pre-treatment of the rats with silymarin and 
the stem bark extract of H. barteri protected the rats 
against the paracetamol-induced hepatic damage. The 
methanol extracts also protected the liver against 
hepatocellular necrosis, pyknotic nuclei, vacoulation 
and kupffer cell hyperplasia caused by paracetamol in a 
dose-dependent manner, except for 500 mg/kg of HB 
which did not protect the hepatocytes against 
paracetamol-induced liver damage as evidenced by 
persistence of intense pyknotic nucei and moderate 
hepatocellular necrosis even though there was 
significant reduction in the serum level of ALT. This may 
occur as a result of interactions among the constituents 
of H. barteri extract or between the plant extract and 
paracetamol. 
Mohammed et al, Afr. J. Pharmacol. Ther. 2017. 6(2): 88-95 
 
A KeSoBAP Publication ©2017. All rights reserved. 
94 
The hepatotoxic effects of CCl4 are largely due to 
bioactivation of CYP2E1 cytochrome enzyme, resulting 
in the formation of trichloromethyl free radicals and 
reactive oxygen species which initiate lipid 
peroxidation, protein oxidation and damage to 
hepatocellular membranes (Johnson and Kroening, 
1998). The damage to the liver is associated with 
leakage of hepatic enzymes (especially ALT and AST) 
into serum resulting in elevation in their serum 
concentration. Serum ALP, bilirubin and total protein 
levels on other hand are related to the function of 
hepatic cell. Increase in serum level of ALP is due to 
increased synthesis, in presence of increasing biliary 
pressure.  In this study, treatment with CCl4 elicited a 
significant increase in serum ALT, AST and ALP levels 
but pre-treatment of the rats with silymarin protected 
the liver against CCl4-induced hepatic damage as 
evidenced by significant reduction in their serum levels. 
Pre-treatment of the rats with H. barteri extract also 
reduced the serum levels of the ALT, AST and ALP 
levels. Histopathological examination of liver sections of 
H. barteri treated groups showed some levels of 
protection against CCl4 intoxication which was evident 
by less hepatocellular necrosis. 
Antioxidants appear to act against disease processes by 
increasing the levels of endogenous antioxidant 
enzymes and decreasing toxic products such as lipid 
peroxidation by-products. Free radicals are easily 
formed when a covalent molecular bond is broken and 
one electron remains with each newly formed atom. 
DPPH is a stable free radical which produces deep 
purple colour in methanol. The principle of this assay is 
based on the reduction of purple coloured methanolic 
DPPH solution in the presence of hydrogen donating 
antioxidants by the formation of yellow coloured 
diphenyl-picryl hydrazine. When DPPH accepts an 
electron donated by an antioxidant compound, the 
DPPH is decolorized, which can be quantitatively 
measured from the changes in absorbance (Saha et al, 
2008). The DPPH studies on H. barteri stem bark extract 
has shown that it possesses antioxidant properties, 
which is further validated by previous reports on its 
high phenolic content (Boampong et al, 2015; Ezekiel et 
al, 2016). Typical phenolics that possess antioxidant 
activity are mainly phenolic acids and flavonoids; and 
studies have shown that hepatoprotective effects of 
plant extracts are associated with phytocompounds rich 
in natural antioxidants (Sharida et al, 2012). Based on 
this, it can be suggested that the observed 
hepatoprotection offered by H. barteri stem bark extract 
may be ascribed to its antioxidant property. 
5.0 Conclusion  
The results obtained showed that the methanol stem 
bark extract of Haematostaphis barteri possesses 
hepatoprotective activities. This lends further support 
on the ethnomedical rationale of its use in managing 
liver diseases. 
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